This report focuses on data findings on the continuum of HIV care submitted by countries in Europe and Central Asia for the 2018 round of reporting on implementation of the Dublin Declaration on Partnership to Fight HIV & AIDS in Europe and Central Asia.

This evidence brief summarises information reported to ECDC by government representatives in 48 countries for Dublin Declaration monitoring in 2016.

This evidence brief reviews the extent to which specific laws and policies may limit access to or uptake of HIV prevention, testing and treatment services for key populations – men who have sex with men, people who inject drugs, sex workers, migrants and prisoners – and highlights priority options for action.​​

This report summarises key issues related to HIV and men who have sex with men in Europe, focusing on the EU/EEA, and identifies priority actions to improve the HIV response for this key population.

This report summarises key issues related to HIV and migrants in Europe, focusing on the EU/EEA, and identifies priority actions to improve the HIV response for this key population.

This report summarises key issues related to HIV testing in Europe, focusing on the EU/EEA, and identifies priority actions to improve testing rates.

This report summarises key issues related to HIV treatment in Europe, focusing on the EU/EEA, and identifies priority actions for improvement.

This report, structured around a four-stage continuum of care in order to provide an understanding of the effectiveness of national responses to HIV, summarises key issues related to the continuum of HIV care in Europe.

This report is an update on the status of the HIV response in the European Union/European Economic Area, as part of ECDC's commitment to monitoring the implementation of the Dublin Declaration in Europe and Central Asia.

This ECDC evidence brief assesses data from a collaborative ECDC and Hornet Gay Social Network rapid survey of a non-representative sample of men who have sex with men in Europe about pre-exposure prophylaxis use for HIV prevention.